Phase 3 Study of Alzheimer Disease Agitation Shows Disagreement with AVP-786.

Published Date: 15 Feb 2024

The primary outcome of change in the Cohen-Mansfield Agitation Inventory did not show statistically significant outcomes when compared to placebo, despite AVP-786 exhibiting inconsistent results in previous trials.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The Boom in ADHD Coaching Has Few Rules

2.

Cancer patients with HIV have demonstrated safety with immune checkpoint inhibitors.

3.

The FDA approves Enhertu for HER2-positive cancers, regardless of tumor type.

4.

Medicaid expansion tied to smaller declines in early-stage cancer detection

5.

Specialist Referrals Are Critical for Functional High-Risk Multiple Myeloma


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot